Gi-Eun Rhie

Gi-Eun Rhie

Auto-generated profile, based on publicly available information

Gi-Eun Rhie

Division of High-Risk Pathogens, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2019 in Sensors
Verified
Journal Article
Open access
PDF file
KKKihyun Kim
Kihyun Kim
NCNamhyun Choi
Namhyun Choi
JJJun Ho Jeon
Jun Ho Jeon
GRGi-Eun Rhie
Gi-Eun Rhie
Jaebum ChooJaebum Choo
Jaebum Choo
Rapid and sensitive detection of botulinum neurotoxins (BoNTs) is important for immediate treatment with proper antitoxins. However, it is difficult to detect BoNTs at the acute phase of infection, owing to its rarity and ambiguous symptoms. To resolve this problem, we developed a surface-enhanced Raman scattering (SERS)-based immunoassay technique for the rapid and sensitive detection of BoNTs. Magnetic beads and SERS nanotags as capture substrates and detection probes, respectively, and Nile Blue A (NBA) and malachite green isothiocyanate (MGITC) as Raman reporter molecules were used for the detection of two different types of BoNTs (types A and B), respectively. The corresponding limits of detection (LODs) were determined as 5.7 ng/mL (type A) and 1.3 ng/mL (type B). Total assay time, including that for immunoreaction, washing, and detection, was less than 2 h.

28 February 2021 in Osong Public Health and Research Perspectives
Verified
Journal Article
Open access
APAe Kyung Park
Ae Kyung Park
IKIl-Hwan Kim
Il-Hwan Kim
JKJunyoung Kim
Junyoung Kim
JKJeong-Min Kim
Jeong-Min Kim
HKHeui Man Kim
Heui Man Kim
EKEun-Jin Kim
Eun-Jin Kim
Since a novel beta-coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019, there has been a rapid global spread of the virus. Genomic surveillance was conducted on samples isolated from infected individuals to monitor the spread of genetic variants of SARS-CoV-2 in Korea. The Korea Disease Control and Prevention Agency performed whole genome sequencing of SARS-CoV-2 in Korea for 1 year (January 2020 to January 2021). A total of 2,488 SARS-CoV-2 cases were sequenced (including 648 cases from abroad). Initially, the prevalent clades of SARS-CoV-2 were the S and V clades, however, by March 2020, GH clade was the most dominant. Only international travelers were identified as having G or GR clades, and since the first variant 501Y.V1 was identified (from a traveler from the United Kingdom on December 22nd, 2020), a total of 27 variants of 501Y.V1, 501Y.V2, and 484K.V2 have been classified (as of January 25th, 2021). The results in this study indicated that quarantining of travelers entering Korea successfully prevented dissemination of the SARS-CoV-2 variants in Korea.

17 October 2019 in Microbiology and Immunology
Verified
Journal Article
Closed access
PDF file
SCSang‐Yoon Choi
Sang‐Yoon Choi
GRGi‐Eun Rhie
Gi‐Eun Rhie
JJJun Ho Jeon
Jun Ho Jeon

31 August 2022 in Osong Public Health and Research Perspectives
Verified
Journal Article
Open access
JKJin-Won Kim
Jin-Won Kim
MLMinji Lee
Minji Lee
HSHwachul Shin
Hwachul Shin
CCChi-Hwan Choi
Chi-Hwan Choi
MCMyung-Min Choi
Myung-Min Choi
GRGi-Eun Rhie
Gi-Eun Rhie
Objectives: Monkeypox outbreaks in nonendemic countries have been reported since early May 2022. The first case of monkeypox in the Republic of Korea was confirmed in a patient who traveled to Europe in June 2022, and an attempt was made to isolate and identify the monkeypox virus (MPXV) from the patient’s specimens.Methods: Clinical specimens from the patient were inoculated in Vero E6 cells. The isolated virus was identified as MPXV by the observation of cytopathic effects on Vero E6 cells, transmission electron microscopy, conventional polymerase chain reaction(PCR), and sequencing of PCR products.Results: Cytopathic effects were observed in Vero E6 cells that were inoculated with skin lesion swab eluates. After multiple passages from the primary culture, orthopoxvirus morphology was observed using transmission electron microscopy. In addition, both MPXV-specific (F3L and ATI) and orthopoxvirus-specific genes (A39R, B2R, and HA) were confirmed by conventional PCR and Sanger sequencing.Conclusion: These results indicate the successful isolation and identification of MPXV from the first patient in the Republic of Korea. The isolated virus was named MPXV-ROK-P1-2022.

1 November 2021 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
IKIl-Hwan Kim
Il-Hwan Kim
BKByung-Hak Kang
Byung-Hak Kang
SSSeung Hee Seo
Seung Hee Seo
YPYe Eun Park
Ye Eun Park
GKGab Jung Kim
Gab Jung Kim
M.M.S.
M.S.
Il-Hwan Kim, Ph.D., Byung-Hak Kang, Ph.D., Seung Hee Seo, M.S., Ye Eun Park, M.S., Gab Jung Kim, Ph.D., Sang Won Lee, Ph.D., Jun Hyeong Jang, Ph.D., Su Kyoung Jo, M.S., Jun Ho Jeon, Ph.D., Jeong-Min Kim, Ph.D., Yoon-Seok Chung, Ph.D., Myung-Guk Han, Ph.D., Sang-Oun Jung, Ph.D., Junyoung Kim, Ph.D., Kyu-Jam Hwang, Ph.D. , Cheon-Kwon Yoo, Ph.D., and Gi-eun Rhie, Ph.D.. Ann Lab Med 2021;41:532-9. https://doi.org/10.3343/alm.2021.41.6.532

8 March 2021 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
DPDeok Bum Park
Deok Bum Park
BABo-Eun Ahn
Bo-Eun Ahn
HSHosun Son
Hosun Son
YLYoung-Ran Lee
Young-Ran Lee
YKYu-Ri Kim
Yu-Ri Kim
GRGi-Eun Rhie
Gi-Eun Rhie
Background: Anthrax and smallpox are high-risk infectious diseases, and considered as potential agents for bioterrorism. To develop an effective countermeasure for these diseases, we constructed a bivalent vaccine against both anthrax and smallpox by integrating a gene encoding protective antigen (PA) ofBacillus anthracisto the genome of the attenuated vaccinia virus strain, KVAC103.Results: Immunization with this bivalent vaccine induced antibodies against both PA and vaccinia virus in a mouse model. We also observed that the efficacy of this vaccine can be enhanced by combined immunization with immunoadjuvant-expressing KVAC103. Mouse groups co-immunized with PA-expressing KVAC103 and either interleukin-15 (IL-15) or cholera toxin subunit A (CTA1)-expressing KVAC103 showed increased anti-PA IgG titer and survival rate againstB. anthracisspore challenge compared to the group immunized with PA-expressing KVAC103 alone.Conclusions: We demonstrated that the attenuated smallpox vaccine KVAC103 is an available platform for a multivalent vaccine and co-immunization of immunoadjuvants can improve vaccine performance.